Global regulatory agencies are mandating a proactive risk management approach for drug sponsors through new initiatives, regulations and guidance. Current regulatory approval and post marketing surveillance process are under public and professional scrutiny to ensure enough is being done to address patient safety.

Wipro partners with its sponsors to facilitate seamless information sharing, monitoring and reporting services to ensure fastest reaction times. Wipro’s drug safety and pharmacovigilence services include

Services

	Drug information services - providing information to consumers and healthcare professionals on dosage, safety, side effects, interactions, storage etc.
	Product complaint management - record from users and maintain a complaint database of all relevant product complaint data such as lot number and expiration date
	ADE monitoring and reporting - record adverse events and maintain safety database
	Custom development of safety signal detection systems, AE capturing & Report systems